Details of the Drug

General Information of Drug (ID: DM4XT5D)

Drug Name

BI 695502

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02272413) Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin Plus Chemotherapy in Patients With Lung Cancer. U.S. National Institutes of Health.